Immunovant, Inc. (IMVT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
29.64 - Open
29.49 - Bid 21.28 x 200
- Ask 36.85 x 200
- Day's Range
28.75 - 29.78 - 52 Week Range
21.43 - 45.42 - Volume
208,610 - Avg. Volume
1,349,581 - Market Cap (intraday)
5.989B - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
-- - EPS (TTM)
-2.82 - Earnings Date Nov 9, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
48.88 - Motley Fool Rating Bearish
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-46.73%
-
Return on Equity (ttm)
-80.10%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-538.22M
-
Diluted EPS (ttm)
-2.82
Balance Sheet and Cash Flow
-
Total Cash (mrq)
797.8M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-238.7M
